Topical rapamycin: a novel approach to facial angiofibromas in tuberous sclerosis

Arch Dermatol. 2010 Jul;146(7):715-8. doi: 10.1001/archdermatol.2010.125.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Administration, Topical
  • Adolescent
  • Angiofibroma / diagnosis
  • Angiofibroma / drug therapy*
  • Angiofibroma / etiology
  • Cheek
  • Diagnosis, Differential
  • Facial Neoplasms / diagnosis
  • Facial Neoplasms / drug therapy*
  • Facial Neoplasms / etiology
  • Female
  • Follow-Up Studies
  • Humans
  • Immunosuppressive Agents / administration & dosage*
  • Sirolimus / administration & dosage*
  • Tuberous Sclerosis / complications*
  • Tuberous Sclerosis / drug therapy

Substances

  • Immunosuppressive Agents
  • Sirolimus